-- conference call and audio web cast on October 9, 2007 --
BELLEVILLE, ON, Oct. 5 /PRNewswire-FirstCall/ - Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company (TSX:BNC), will be discussing the U.S. Department of Agriculture (USDA) comment on a field trial for its E. coli O157:H7 cattle vaccine during a:
Conference Call & Audio Web Cast
Tuesday, October 9, 2007
9:00 a.m. (Eastern)
To participate in the teleconference, call 416-644-3414/toll-free 1-800-733-7571.
A listen-only audio web cast will be available at:
A replay of the conference call will be available until October 16, 2007 by calling (416) 640-1917 or toll-free 1-877-289-8525 (passcode: 21249516 followed by the number sign).
The web cast will be available for replay using the above links until January 9, 2008.
About Bioniche Life Sciences
Bioniche Life Sciences Inc. is a research-based, technology-driven Canadian biopharmaceutical company focused on the discovery, development, manufacturing, and marketing of proprietary products for human and animal health markets worldwide. The fully-integrated company employs approximately 195 skilled personnel and has three operating divisions: Human Health, Animal Health, and Food Safety. The Company's primary goal is to develop proprietary cancer therapies supported by revenues from marketed products in human and animal health. For more information, please visit http://www.Bioniche.com.
|SOURCE Bioniche Life Sciences Inc.|
Copyright©2007 PR Newswire.
All rights reserved